Price
76.03
+0.15%52W Range
Market Cap
₹762.00 Cr
Traded: ₹0.20 Cr (0.03%) 0.0x
Free Float: ₹206.43 Cr (0.10% of FF traded)
Volume · 60D trend
26.87 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | +9.0% | +12.0% | +14.0% | -- | +10.0% | Stable |
| Profit | +4.0% | +10.0% | +3.0% | -- | -4.0% | Decelerating |
| Return | +5.0% | +2.0% | +6.0% | -12.0% | -- | Stable |
| ROE | +13.0% | +14.0% | +14.0% | -- | -- | Stable |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 194 | 202 | 197 | 186 | 186 | 198 | 160 | 166 | 138 | 164 | 172 | 150 | 161 | 157 |
| Expenses | 178 | 182 | 178 | 174 | 176 | 179 | 145 | 149 | 127 | 145 | 148 | 132 | 148 | 143 |
| Operating Profit | 16 | 20 | 19 | 12 | 10 | 19 | 15 | 17 | 11 | 19 | 24 | 18 | 14 | 14 |
| OPM % | 8.0% | 10.0% | 10.0% | 6.0% | 6.0% | 9.0% | 9.0% | 10.0% | 8.0% | 12.0% | 14.0% | 12.0% | 9.0% | 9.0% |
| Other Income | 3 | -1 | 2 | 1 | 3 | 1 | 1 | 3 | 4 | 3 | 4 | 2 | 3 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit Before Tax | 17 | 16 | 18 | 10 | 11 | 17 | 13 | 18 | 12 | 20 | 25 | 18 | 15 | 13 |
| Tax % | 32.0% | 25.0% | 25.0% | 23.0% | 24.0% | 28.0% | 22.0% | 17.0% | 22.0% | 22.0% | 24.0% | 23.0% | 24.0% | 25.0% |
| Net Profit | 11 | 12 | 13 | 8 | 8 | 12 | 10 | 15 | 10 | 15 | 19 | 14 | 12 | 10 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 1.1 | 1.2 | 1.3 | 0.8 | 0.8 | 1.2 | 1.0 | 1.5 | 0.9 | 1.5 | 1.9 | 1.4 | 1.2 | 1.0 |
| Sales Growth (YoY) | -- | 2.0% | 23.6% | 12.0% | 35.2% | 20.9% | -7.3% | 11.0% | -14.6% | 4.2% | 24.1% | 29.9% | 38.8% | 22.0% |
| Sales Growth (QoQ) | -- | 2.5% | 5.9% | 0.0% | -6.1% | 23.8% | -3.6% | 20.3% | -15.8% | -4.7% | 14.7% | -6.8% | 2.5% | -- |
| OP Growth (YoY) | 60.0% | 5.3% | 26.7% | -29.4% | -9.1% | 0.0% | -37.5% | -5.6% | -21.4% | 35.7% | -- | -- | -- | -- |
| OP Growth (QoQ) | -20.0% | 5.3% | 58.3% | 20.0% | -47.4% | 26.7% | -11.8% | 54.5% | -42.1% | -20.8% | 33.3% | 28.6% | 0.0% | -- |
| Profit Growth (YoY) | -- | -6.3% | 30.1% | -49.4% | -12.7% | -18.9% | -45.9% | 8.8% | -19.1% | 59.7% | 105.3% | 39.4% | 60.1% | 7.7% |
| EPS Growth (YoY) | -- | -5.7% | 30.1% | -49.3% | -12.6% | -18.9% | -46.1% | 8.7% | -18.8% | 59.4% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | -12.7% | 76.3% | -8.4% | -33.1% | 20.4% | -31.3% | 57.9% | -37.9% | -19.9% | 38.4% | 17.9% | 21.9% | -- |
| OP Margin | -- | 9.9% | 9.6% | 6.5% | 5.4% | 9.6% | 9.4% | 10.2% | 8.0% | 11.6% | 13.9% | 12.0% | 8.7% | 8.9% |
| Net Margin | -- | 5.9% | 6.6% | 4.3% | 4.3% | 6.1% | 6.3% | 9.0% | 7.3% | 9.2% | 11.1% | 9.3% | 7.5% | 6.4% |
| Material Cost % | -- | 75.0% | 77.0% | 78.0% | 82.0% | 75.0% | 76.0% | 75.0% | 76.0% | 74.0% | 73.0% | 74.0% | 80.0% | 78.0% |
| Employee Cost % | -- | 3.0% | 4.0% | 4.0% | 3.0% | 3.0% | 3.0% | 3.0% | 4.0% | 3.0% | 3.0% | 3.0% | 3.0% | 3.0% |
| P/S | 0.98 | 1.03 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 17.24 | 19.35 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 2.16 | 2.26 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Investor Presentation for Q1 FY 2026-27
Disclosure under Regulation 30 of SEBI (LODR), 2015 regarding Change in Management.
Disclosure of Announcement under Regulation 30 of SEBI (LODR), 2015
Submission of Scrutinizer Report and Voting Results for the 66th Annual General Meeting of the Company
Outcome of the 66th Annual General Meeting of Anuh Pharma Limited held on Wednesday, 12th August, 2026
Newspaper Publication of the Unaudited financial results for the Quarter ended 30th June, 2026, published in the Financial Express in English Language and Mumbai Lakshdeep in Marathi Language ....
Unaudited Financial Results for the Quarter ended 30th June, 2026.
Request received for Withdrawal of application for reclassification of shareholding from "Promoter & Promoter Group'' to ''Public Category''.
Adoption of Revised Policy of Related Party Transactions.
To consider and approve the Unaudited Financial results along with the Limited Review Report for the quarter ended 30th June, 2026, Request received for withdrawal of application for reclassification ....
Pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 that a meeting of the Shareholders of the Company will be held on Wednesday, 12th August, ....
This is to inform to the stock exchange regarding dispatch of physical communication to shareholders who have not registered their email address.
Pursuant to the provisions of Regulation 34(1) of the SEBI (Listing Obligation and Disclosures Requirements) Regulations, 2015 please find enclosed herewith the copy of the Annual Report ....
In terms of the provisions of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find attached herewith Notice of the 66th Annual General Meeting of the ....
Compliance Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June, 2026 received from Bigshare Services Private ....
Intimation regarding the closure of Trading Window for dealing in Securities of the Company shall remain closed from Wednesday, 01st July, 2026 till the expiry of 48 hours after the declaration ....
Clarification for Newspaper Publication made on 19th June, 2026
Disclosure under Regulation 30 of the SEBI LODR regarding receipt of Demand Order under Section 156 and Penalty Order under Section 270 of the Income Tax Act, 1961.
Newspaper Publication for transfer of equity shares of the Company for which Dividend has not been claimed by shareholders for seven consecutive years or more to Investor Education and ....
Submission of Annual Secretarial Compliance Report for the Financial Year ended 31st March, 2026.
Investor Presentation for Q4 FY 2025-26
Intimation for filing of the application for reclassification of shareholders from Promoter Group to Public Category
Intimation for the Resolution for reclassification of shareholders from Promoter group to Public category
Newspaper Publication of the Audited financial results for the Quarter and Year ended 31st March, 2026, published in the Financial Express in English Language and Mumbai Lakshdeep in Marathi ....
Adoption for policy for implementation of NFRA circular
Appointment of Scrutinizer for the 66th Annual General Meeting.
66th Annual General Meeting will be held on Wednesday, 12th August, 2026 through Video Conferencing and other audio visual means.
Adoption of Memorandum of Association (MOA) and Articles of Association (AOA) as per Companies Act, 2013.
Granting Authorization to Key Managerial Personnel for Determination of Materiality of Events.
Intimation for re-classification of shareholders from Promoter group to public category
Re-appointment of Cost Auditor
Appointment of Mr. P.N. Rao as General Manager - Quality.
Appointment of Internal Auditor.
Intimation for Re-appointment of Directors retiring by rotation.
The record date for dividend is fixed and is enclosed herewith
Final Dividend of Rs. 1.50 (30%) per equity shares of Face Value of Rs. 5 each for the Financial year ended 31/03/2026
Financial Results for the Financial Year ended 31/03/2026
Consider and approve the Audited Financial Results for the Financial Year ending 31st March, 2026, and recommendation of Final Dividend for the Financial Year 2025-26, subject to the approval ....
Intimation for requests received from Persons belonging to Promoter Group seeking reclassification from Promoter Group to Public.
Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia, to consider and approve Audited Financial Results For The ....
Approval from World Health Organization (WHO) Prequalification (WHO PQ) for Amodiaquine Hydrochloride USP
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Newspaper Publication for Second 100 Days Campaign - "Saksham Niveshak."
Newspaper Publication regarding notice to shareholders for Special Window for transfer and dematerialisation (demat) of physical shares in reference to SEBI Circular dated January 30, 2026
Compliance Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2026 received from Bigshare Services Private ....
Intimation regarding the closure of Trading Window for dealing in Securities of the Company shall remain closed from Wednesday, 01st April, 2026 till the expiry of 48 hours after the declaration ....
Completion of European Directorate for the Quality of Medicines & Healthcare (EDQM) Audit and our facilities were found compliant under the Audit
Newspaper Publication regarding notice to shareholders for Special Window for transfer and dematerialisation (demat) of physical shares in reference to SEBI Circular dated January 30, 2026
Investor Presentation for Q3 FY 2025-26
Newspaper publication of the Un-Audited financial results for the Quarter ended 31st December, 2025, published in the Financial Express in English Language and Mumbai Lakshdeep in Marathi ....
Annual Reports
16Credit Ratings
6Concalls
27Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025May 2025
31 May 2025Nov 2024
30 Nov 2024Feb 2024
29 Feb 2024Aug 2023
31 Aug 2023Jun 2023
30 Jun 2023Feb 2023
28 Feb 2023Aug 2022
31 Aug 2022May 2022
31 May 2022Feb 2022
28 Feb 2022Feb 2022
28 Feb 2022Nov 2021
30 Nov 2021Aug 2021
31 Aug 2021May 2021
31 May 2021Feb 2021
28 Feb 2021Feb 2021
28 Feb 2021Nov 2020
30 Nov 2020Aug 2020
31 Aug 2020Jun 2020
30 Jun 2020Aug 2019
31 Aug 2019Dec 2017
31 Dec 2017Feb 2016
29 Feb 2016Dec 2015
31 Dec 2015Sep 2015
30 Sept 2015Aug 2015
31 Aug 2015Held by ETFs
1 ETFs hold ANUHPHR · sorted by weight
Held by Mutual Funds
1 schemes hold ANUHPHR · sorted by weight